Current Report: Takeda Pharmaceutical
Takeda’s price per share was $14.31 as of yesterday's market close. One year ago its price was $17.20.
-
-
Biotech Shares Too Risky? Here's An ETF For Safely Avoiding The Volatility
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or derivatives....
-
1 Stock To Buy, 1 To Dump When Markets Open: Jabil, Vertex Pharmaceuticals
Stocks on Wall Street ended the week on a high note, with indexes looking past inflation worries as most major averages closing within sight of their recent records. The NASDAQ Composite...
-
Chasing Olympic Glory: 2 Japanese ETFs That May Win Big In Run-Up To The Games
The Tokyo Olympics will begin on July 23. Japan is the host nation for the events, which will be held after a one-year delay due to the pandemic.When the Olympics' host country is initially...
-
2 ETFs To Invest Internationally And Hedge Against Strong USD
Investing in international equities offers exposure to the growth of global industry titans and boosts portfolio diversification. One key concern: how moves in foreign exchange rates could...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
